President Joe Biden bestowed the National Medal of Technology and Innovation on a vaccine maker that allegedly hid a child's death in a COVID-19 clinical trial from Americans, and the Food and Drug Administration may have known about the purported subterfuge.

The U.S. government has awarded $176 million to Moderna (MRNA.O), opens new tab to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.

Shares of the Cambridge, Massachusetts-based company rose more than 2% to $118.32 in early trade.

Moderna said on Monday its combination vaccine to protect against both Covid and influenza generated a stronger immune response in adults aged 50 and over when compared to separate shots against the viruses in a late-stage trial.

In the study, the combination using messenger RNA technology generated greater antibodies than currently marketed traditional flu vaccines and Moderna’s Spikevax mRNA Covid shot, the company said.

Pharmaceutical giants Moderna and Merck announced promising results from a clinical trial testing a combined treatment of an mRNA vaccine and immunotherapy for skin cancer. Melanoma patients who received monthly mRNA vaccines and Merck’s Keytruda immunotherapy had lower chances of cancer recurrence and spread, as well as higher survival rates, than those who received Keytruda alone.

 Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency.

The FDA was expected to make a decision on the RSV shot on Sunday. The agency has not informed Moderna of any issues related to the vaccine’s safety, efficacy or quality that would prevent its approval, the biotech company said in a release.

Moderna CEO Stéphane Bancel said Thursday that with the help of AI scientists will likely “understand most diseases” in the next three to five years, in what will be a “first for humans on the planet.”

“If you understand the disease, you will find a way to go fix it,” Bancel said at Semafor’s World Economy Summit. “The reason we still have people dying of cancer, people suffering from Alzheimers, is we do not understand the fundamental biology of those diseases.”

 Moderna has more to offer beyond its Covid vaccine.

The biotech company Wednesday announced positive clinical trial data on three experimental vaccines against other viruses. The company is moving those shots to final stage studies, it said.